Texas Oncology - Arlington South — Arlington, Texas

Texas Oncology - Arlington South is a clinical research site located in Arlington, Texas, United States 76014.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology - Arlington South has participated in 5 clinical trials.

Therapeutic areas: Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, Non Small Cell Lung Cancer, Non-Small-Cell Lung Adenocarcinoma.

Sponsors: Oncolytics Biotech, US Oncology Research, Synta Pharmaceuticals Corp..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Arlington South?

Texas Oncology - Arlington South has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Arlington South conducted?

Texas Oncology - Arlington South has 5 clinical trials on record. Their work covers Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, Non Small Cell Lung Cancer, Non-Small-Cell Lung Adenocarcinoma.

Is Texas Oncology - Arlington South accredited by Crixeo Health?

Yes — Texas Oncology - Arlington South holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - Arlington South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.